Bill Type
Congress Name
Long Title
AN ACT PRESCRIBING THE PROPER LABELING OF PHARMACEUTICAL PRODUCTS WHICH ACT ON THE BRAIN AND CENTRAL NERVOUS SYSTEM SO AS TO IMPAIR DANGEROUSLY THE CONSUMER'S ABILITY TO CARRY OUT CERTAIN ACTIVITIES AND PROVIDING PENALTIES FOR VIOLATION THEREFOR
Date filed
November 15, 2007
Scope
Legislative History
| House Bill/Resolution NO. HB03085 |
| FULL TITLE : AN ACT PRESCRIBING THE PROPER LABELING OF PHARMACEUTICAL PRODUCTS WHICH ACT ON THE BRAIN AND CENTRAL NERVOUS SYSTEM SO AS TO IMPAIR DANGEROUSLY THE CONSUMER'S ABILITY TO CARRY OUT CERTAIN ACTIVITIES AND PROVIDING PENALTIES FOR VIOLATION THEREFOR |
| SHORT TITLE : "Pharmaceutical Labeling (Warning of Cognitive Function Impairment) Act of 2007" |
| ABSTRACT : The bill requires pharmaceutical companies to properly label drugs that cause impairment of certain cognitive functions thus affecting the ability to perform certain activities. |
| PRINCIPAL AUTHOR/S : SANTIAGO, NARCISO III D. |
| DATE FILED : 2007-11-15 |
| SIGNIFICANCE: NATIONAL |
| CO-AUTHORS : |
| 1. Teodoro |
| CO-AUTHORS (Journal Entries) : |
| 1. Almario (038 ) |
| ACTIONS TAKEN BY THE COMMITTEE ON RULES |
| REFERRAL TO THE COMMITTEE ON TRADE AND INDUSTRY ON 2007-11-21 |
Abstract
The bill requires pharmaceutical companies to properly label drugs that cause impairment of certain cognitive functions thus affecting the ability to perform certain activities.
Disclaimer
Note: Legislative history and other information accessed from Congress Legis. Information as of April 20, 2022.